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SUMMARY
Successful mitosis requires that cyclin B1:CDK1 ki-
nase activity remains high until chromosomes are
correctly aligned on the mitotic spindle. It has there-
fore been unclear why, in mammalian oocyte
meiosis, cyclin B1 destruction begins before chro-
mosome alignment is complete. Here, we resolve
this paradox and show that mouse oocytes exploit
an imbalance in the ratio of cyclin B1 to CDK1 to con-
trol CDK1 activity; early cyclin B1 destruction reflects
the loss of an excess of non-CDK1-bound cyclin B1
in late prometaphase, while CDK1-bound cyclin B1
is destroyed only during metaphase. The ordered
destruction of the two forms of cyclin B1 is brought
about by a previously unidentified motif that is
accessible in free cyclin B1 but masked when cyclin
B1 is in complex with CDK1. This protects the CDK1-
bound fraction from destruction in prometaphase,
ensuring a period of prolonged CDK1 activity suffi-
cient to achieve optimal chromosome alignment
and prevent aneuploidy.
INTRODUCTION
CDK1 is the only cyclin-dependent kinase that is essential for the
eukaryotic cell cycle (Santamarı´a et al., 2007). Throughout early
mitosis, CDK1 is activated by its binding partner cyclin B1. Cyclin
B1 must be maintained at a level sufficient to generate enough
cyclin B1:CDK1 activity (‘‘CDK1 activity’’) to drive the early
stages of cell division (Gavet and Pines, 2010). By monitoring
the status of kinetochore-microtubule attachments, spindle
checkpoint proteins prevent the destruction of cyclin B1, thereby
inhibiting anaphase until all chromosomes have congressed and
their kinetochores have established stable attachments (Lara-
Gonzalez et al., 2012). Thereafter, a sharp drop in CDK1 activity
via cyclin B1 destruction is also important to drive the events of
mitotic exit (Sullivan and Morgan, 2007).
The goal of the spindle checkpoint is to attenuate the activity of
the anaphase-promoting complex or cyclosome (APC/C), an E3
ligase that directs the degradation of a number of cell cycle
proteins. To ensure accurate passage through all stages of chro-
mosome alignment and segregation, the APC/C must process
its substrates in strict order, an order largely achieved via distinct
substrate degradation motifs. The most well known of these mo-
tifs is the classic destruction motif, the D-box, that directs cyclin
B1 destruction in metaphase (Glotzer et al., 1991).
In the absence of checkpoint activity, the APC/C and its co-
activator Cdc20 form a bipartite co-receptor for D-box docking
(He et al., 2013). This allows cyclin B1 to be ubiquitinated onmul-
tiple lysine residues and to be delivered to the 26S proteasome
for destruction (Yamano et al., 1998). Prior to chromosome align-
ment, each unattached kinetochore generates a checkpoint
signal, which is sufficient to prevent Cdc20 from binding to the
D-box of metaphase substrates (Lara-Gonzalez et al., 2012).
Chromosome misalignment in mitosis therefore strongly inhibits
cyclin B1 destruction to prevent premature chromosome segre-
gation and minimize the possibility of generating aneuploid
daughter cells. Metaphase, the establishment of stable end-on
kinetochore-microtubule attachments, coincides almost exactly
with the destruction of cyclin B1, which is only initiated once the
last chromosome aligns on the metaphase plate (Clute and
Pines, 1999; Hagting et al., 2002).
Female mammalian meiosis is also driven by CDK1 activity
(Ledan et al., 2001) and governed by the same checkpoint ma-
chinery as mitosis (Gorbsky, 2015). Yet, unlike mitosis, oocyte
meiosis I (MI) is characterized by a lengthy period of cyclin B1
destruction, which initiates several hours ahead of metaphase.
This destruction takes place before chromosome alignment is
achieved, prior to the stabilization of kinetochore attachments,
and while checkpoint proteins remain on kinetochores (Brunet
et al., 1999; Davydenko et al., 2013; Gui and Homer, 2012; Kita-
jima et al., 2011; Lane and Jones, 2014; Lane et al., 2012;
Nagaoka et al., 2011; Sebestova et al., 2012). Indeed, at the initi-
ation of cyclin B1 destruction, nearly half of all mouse oocytes
have chromosomes located away from the spindle equator
(Lane et al., 2012).
Surprisingly, however, despite a prolonged period of cyclin B1
destruction ahead of metaphase I, the vast majority of mouse
oocytes achieve chromosome alignment and undergo a division,
which produces an egg with the correct complement of chromo-
somes. This situation raises two major questions: how does
cyclin B1 evade the spindle checkpoint in oocytes and why
does this early loss of cyclin B1 not result in eggs with higher fre-
quencies of aneuploidy?
Here, we show that, inmouse oocytes, cyclin B1 is in excess of
CDK1, the opposite of the situation in mitosis (Arooz et al., 2000).
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This provides the oocyte with two pools of cyclin B1, which are
then destroyed over different time periods: an excess of free
cyclin B1, which is preferentially destroyed in late prometa-
phase, and a pool of CDK1-bound cyclin B1, which is preserved
until metaphase. Known prometaphase APC/C substrates such
as cyclin A2, which must be destroyed to allow passage into
metaphase, contain motifs in addition to the D-box, which
make their destruction less reliant on high levels of checkpoint-
free Cdc20, thereby permitting them to escape full checkpoint
inhibition (Di Fiore and Pines, 2010; Wolthuis et al., 2008; van
Zon and Wolthuis, 2010; Boekhout and Wolthuis, 2015). Here,
we uncover such a motif in cyclin B1. The location of this motif,
masked within the cyclin B1:CDK1 interface, ensures that only
free cyclin B1 is destroyed initially (when the checkpoint is active)
while CDK1 activity is preserved. We show how this degron
masking mechanism allows the activity of cyclin B1:CDK1 to
be tightly regulated and to increase the fidelity of meiosis by
allowing a prolonged period for chromosome alignment.
RESULTS
Cyclin B1 Destruction Initiates Ahead of Metaphase in
MI Mouse Oocytes
To minimize the risk of aneuploidy, cyclin B1 destruction initiates
at the onset of metaphase in mitosis. In contrast, cyclin B1
destruction initiates in prometaphase in MI mouse oocytes,
approximately 3 h ahead of anaphase and before chromosomes
have fully congressed. This seemingly precocious destruction of
cyclin B1 has been considered to be erroneous. However, this is
at odds with the low rates of aneuploidy observed in mouse
oocytes.
To investigate how mouse oocytes continue to correct MI
chromosome alignment despite falling levels of cyclin B1, we
initially designed and tested two fluorescent non-CDK1-binding
cyclin B1 constructs (Figure 1A). We expected that both would
report the destruction timing of cyclin B1 without perturbing
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Figure 1. Cyclin B1 Destruction Begins
ahead of Chromosome Alignment in MI
Mouse Oocytes
(A) Schematic of cyclin B1 constructs: wild-type cy-
clin B1 (WT-B1-V), Y170A cyclin B1 (Y170A-B1-V),
andtheN-terminal90aminoacidsofcyclinB1 tagged
with venus fluorescent protein (VFP) (D-box-B1-V).
(B) Mean destruction profiles of WT-B1-V (n = 16
oocytes), Y170A-B1-V (n = 62), and D-box-B1-V
(n = 34) in maturing MI mouse oocytes. Error bars ±
SEM. See also Figure S1.
(C) Representative images of maturing spindles at
times indicated post GVBD in oocytes expressing
Map7-GFP (microtubules, green) and SiR-DNA
(DNA, red). Scale bar, 10 mm
CDK1 activity. A non-CDK1-binding cyclin
B1 reporter was important since, although
fluorescent wild-type cyclin B1 expres-
sion (WT-B1-V) reports the initiation of
endogenous cyclin B1 destruction (Reis
et al., 2007), evenmoderate levels of over-
expression can delay polar body (PB1)
extrusion and increase the proportion of oocytes that arrest in
MI. As expected, destruction of a full-length, non-CDK1-binding
cyclin B1 reporter (Bentley et al., 2007; Goda et al., 2001) initi-
ated in prometaphase, ahead of chromosome alignment, and
generated a destruction profile almost identical to that of WT-
B1-V (Figures 1B and 1C).
The D-box of Cyclin B1 Is Not Sufficient to Promote
Prometaphase Cyclin B1 Destruction in MI
As inmitosis, theD-box is essential for all cyclinB1degradation in
mouseoocytes.Wehavepreviously demonstrated this inmeiosis
I and II for cyclin B1, which lacks the N-terminal 90 amino acids
containing the D-box (Madgwick et al., 2004; Nixon et al., 2002;
Herbert et al., 2003). Surprisingly, however, the D-box is not
sufficient to generate aWT-B1destructionprofile. A truncated re-
porter that contained the canonical D-box sequence and lysine
residues necessary for APC/CCdc20 recognition and subsequent
proteolysis (Yamano et al., 1998; Pines, 2011), was not targeted
until 80–90 min after Y170A-B1-V (Figures 1B). This did not
seem tobedue to differences in protein synthesis rates or relative
expression of the constructs (Figures S1A and S1B).
The initiation of D-box-B1-V destruction appeared to correlate
with chromosome alignment (Figures 1A–1C), suggesting that
D-box-B1-V targeting is inhibited by the spindle checkpoint to
a greater extent than that of Y170A-B1-V. In support of this
hypothesis, when oocytes were arrested in prometaphase
with 100 nM nocodazole to stimulate a persistent checkpoint,
gradual destruction of Y170A-B1-V was still permitted, yet
D-box-B1-V destruction was prevented (Figure 2A). In contrast,
where the spindle checkpoint was inhibited by theMps1 inhibitor
reversine, both constructs were degraded almost synchro-
nously (Figure 2B), demonstrating that Y170A-B1-V is not simply
a better target for ubiquitination by the APC/C but that the
destruction of D-box-B1-V is restrained by the checkpoint to a
far greater extent. Our observations in nocodazole imply that
Y170A-B1-V destruction has a lower requirement for Cdc20
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Figure 2. D-box-Only Recognition Is Not Sufficient for a Normal Cyclin B1 Destruction Profile
(A) Mean levels of Y170A-B1-V (n = 62 for 100 nM; n = 22 for 500 nM), D-box-B1-V (n = 31), n167-B1-V (n = 28), and n190-B1-V (n = 33) in MI oocytes following
incubation in either 100-nM or 500-nM nocodazole as indicated. Control Y170A-B1-V and n190-B1-V are included as broken traces.
(legend continued on next page)
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than D-box-B1-V. Indeed, when we prevented the prometa-
phase increase in Cdc20 levels with a morpholino oligo (Fig-
ure 2C; MO short incubation) the resultant expression profiles
mimicked those in 100 nM nocodazole. As we have previously
shown for WT-B1 after the same Cdc20 MO incubation,
Y170A-B1-V destruction was still permitted (albeit at a reduced
rate) despite lower Cdc20 levels (Reis et al., 2007). However,
D-box-B1-V was stabilized. These data strongly suggest that
the D-box-B1 reporter lacks regions that would otherwise permit
a period of destruction in prometaphase.
Aconcentration of 100nMnocodazole is theminimumrequired
to inhibit anaphase and arrest oocytes in late prometaphase.
Increasing the dose of nocodazole to 500 nM further stabilized
Y170A-B1-V levels, demonstrating that Y170A-B1 destruction
is responsive to thestrengthof thespindlecheckpoint (Figure2A).
Similarly, increasing the length of the Cdc20MO incubation (long
MO incubation; Figure 2C) delayed Y170A-B1 destruction by an
additional 2 h. To further demonstrate the essential role of the
APC/Ccdc20 in both prometaphase and metaphase cyclin B1
destruction, we used an APC3 MO. The APC3 subunit is known
to bind the IR motif in the tail of APC/C activators, and its deple-
tion severely disrupts APC/C activity, resulting in the inhibition of
cyclin A, cyclin B1, and securin degradation inmitosis (Izawa and
Pines, 2011). In an analogous experiment, we incubated oocytes
with an APC3MOand found that all oocytes failed to degrade cy-
clin B1 following release from germinal vesicle (GV) arrest; this
was not the case with a 5-base-mismatch MO (Figure 2D). This
provides strong evidence that APC/Ccdc20 activity is responsible
for both early and late stages of cyclin B1 destruction.
A Second Destruction Motif Exists within the NTH of
Cyclin B1 to Promote Destruction in Prometaphase
To determine the region of cyclin B1 necessary to recover prom-
etaphase destruction, we made stepwise extensions to the
C terminus of D-box-B1. The addition of residues between 167
and 190 restored prometaphase destruction (Figures 2E and
2F; compare n167-B1-V and n190-B1-V). Furthermore, when
oocytes were arrested in prometaphase with the use of 100-nM
nocodazole, or when Cdc20 levels were knocked down, n190-
B1-V remained a destruction target like Y170A-B1-V, while
n167-B1-V was stabilized like D-box-B1-V (Figures 2A and 2C).
Between residues 167 and 190 lies the N-terminal helix (NTH)
of cyclin B1 (residues 170–196; Figure 3A), an integral part of the
CDK1 binding interface (Brown et al., 2015). Fusing the NTH to
the D-box-B1 (D-box-B1+NTH) fully rescued a Y170A-B1-like
destruction profile, effectively converting D-box-B1 to a prome-
taphase destruction target (Figures 3B, 3C, and S2B), demon-
strating that the critical region lies within the NTH. To identify
residues necessary for prometaphase targeting, we made a
series of point mutations in the D-box-B1+NTH and n190-B1
reporters and found specific mutations that delayed the destruc-
tion of the expressed protein by 60–80 min (Figure S2). This
mutagenesis revealed 7 residues, DIY (173–175) and LRQL
(178–181), which we suggest constitute a novel motif (hereafter,
named the ProMetaphase [PM] motif) able to direct APC/C-
mediated proteolysis of free cyclin B1 in late prometaphase.
Indeed, mutation of these 7 residues in Y170A-B1-V generated
a full-length cyclin B1 mutant (PMmutB1-V; Figure 3A), which
was now destroyed at the same time as D-box-B1-V (Figures
3B, 3C, and S2D). Further evidence that the PM motif confers
prometaphase destruction was provided by the stability of
PMmut-B1 protein in the presence of nocodazole (Figure 3D).
The distinct order of Y170A-B1-V and PMmut-B1-V destruc-
tion targeting was not an artefact of dissimilar levels of exoge-
nous expression nor a result of differences in translation effi-
ciency (Figures S3A–S3C and S4G). Furthermore, confocal
microscope scanning through the MI spindle of oocytes ex-
pressing PMmutB1-V and Y170A-B1-V demonstrated no
discernible difference in localization, despite a clear shift in
the timing of destruction targeting (Figure S3D). Together,
these studies identify a PM motif within the NTH of cyclin B1
that leads to initiation of its destruction in prometaphase.
We have referred to the sequence we have identified as an
important signaling ‘‘motif’’ rather than a degron since the term
degron is used inconsistently within the literature (Guharoy
et al., 2016). However, it is worth noting that the PM motif also
fits an established definition of a degron: a protein element that
confers instability, important in the regulation of protein degrada-
tion rates (Varshavsky, 1991).
Cyclin B1 Levels Are in Excess and Do Not Report CDK1
Activity in Mouse Oocytes
The location of the PM motif in cyclin B1 is potentially significant
given that the NTH is an integral part of the CDK1 binding inter-
face (Figure 4A; Brown et al., 2015) and in context of the ratio of
cyclin B1 to CDK1 in mouse oocytes. Previously, cyclin B1 has
been reported to exist in excess of CDK1 in prophasemouse oo-
cytes, the opposite of the situation in mitosis, where CDK1 is in
excess of cyclin B1 (Arooz et al., 2000).We confirmed this finding
in late prometaphase oocytes by immunoblotting and found cy-
clin B1 to be in 6-fold excess over CDK1 (Figures S4A–S4E).
Consequently, it is expected that there will be a large pool of
non-CDK1-bound cyclin B1 in prometaphase mouse oocytes.
The position of the PM motif within the NTH suggests how the
cellular destruction machinery is able to discriminate between
CDK1-bound and free cyclin B1. We propose that early cyclin
(B) Mean destruction profiles of Y170A-B1-V (n = 20) and D-box-B1-V (n = 17) on addition of reversine to inhibit checkpoint activity. Traces are aligned to the
addition of reversine at 3.5 h post GVBD. PB1s emerged over the period shown.
(C) Mean levels of Y170A-B1-V (n = 38 for short incubation; n = 20 for long incubation), D-box-B1-V (n = 20), n167-B1-V (n = 20), and n190-B1-V (n = 20) in oocytes
following either a short (1.5–2 h) or a long (6–7 h) Cdc20MO incubation period. Note that oocytes do not extrude a PB1 in either dose of nocodazole or after either
Cdc20 MO incubation period.
(D) Mean levels of Y170A-B1-V in untreated oocytes (n = 62) or in oocytes released from prophase arrest 6 h after an injection of either an APC3MO (n = 18) or an
APC3 5-base pair-mismatch MO (5-bp mm; n = 25).
(E) Schematic of cyclin B1 truncations: n167-B1-V and n190-B1-V, the N-terminal 167 and 190 amino acids of cyclin B1 tagged with VFP.
(F) Mean destruction profiles Y170A-B1-V (n = 62), D-box-B1-V (n = 34), n167-B1-V (n = 38), and n190-B1-V (n = 38) in maturing MI oocytes.
Error bars ± SEM throughout.
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B1 destruction represents primarily the loss of free, non-CDK1-
bound cyclin B1, targeted in prometaphase via its D-box and
PM motif, a situation that is mimicked by the non-CDK1-binding
Y170A-B1 mutant. However, since only the D-box is accessible
in CDK1-bound cyclin B1, bound cyclin B1 destruction is initially
prevented, a situation that is mimicked by the D-box-B1 or
PMmut-B1 reporter. This led us to predict that CDK1 activity re-
mains elevated during prometaphase destruction of free cyclin
B1 and falls only later when CDK1-bound cyclin B1 is destroyed.
To test this hypothesis, we used a real-time live assay based
on the CDK1 fluorescence resonance energy transfer (FRET)
biosensor first developed for use in mitosis (Gavet and Pines,
2010). After validating the sensor for use in oocytes (Figure S5),
we found that CDK1 activity was remarkably stable through
prometaphase. During the first 1.5 h of cyclin B1 destruction,
CDK1 activity was preserved, declining only in the final hour
before PB1 extrusion as a result of D-box directed cyclin B1
destruction (Figure 4B). Indeed, though metaphase is not
coupled to the initiation of cyclin B1 destruction in oocytes, the
decline in CDK1 activity closely coincides with the time at which
stable end-on kinetochore-microtubule attachments are formed
and checkpoint proteins are maximally depleted from kineto-
chores (Kitajima et al., 2011; Lane et al., 2012). We suggest
that this prolonged plateau of CDK1 activity explains how oo-
cytes are able to continue to align their chromosomes despite
the early loss of cyclin B1.
B
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Figure 3. A Second Destruction Motif within
the NTH of Cyclin B1 Promotes Prometa-
phase Cyclin B1 Destruction
(A) NTH sequence detail in WT-B1-V, Y170A-B1-V,
and a PM-motif mutation (PMmut-B1-V). Yellow
and pink boxes relate to sequence changes high-
lighted in (B).
(B) Destruction timing of cyclin B1 truncations and
mutants. Other than WT-B1-V, all lack the ability to
bind CDK1 and act as reporters of destruction
timing without perturbing endogenous CDK1 ac-
tivity. Schematic representations of constructs are
shown to the right (yellow and pink marks denote
sequence changes highlighted in A). The length of
each bar to the left indicates destruction timings in
minutes, where time 0 =maximal destruction. PB1s
were extruded over the period shaded in gray.
Open white bars indicate the timing of 75% protein
destruction. The light blue extensions indicate 50%
protein destruction, and dark blue indicates 25%
protein destruction.
(C) Mean Y170A-B1-V, D-box-B1-V, D-box-
B1+NTH (n = 22), and PMmut-B1-V (n = 32)
destruction profiles in maturing MI oocytes (See
Figure S2 for destruction profiles of additional
truncations and mutants).
(D) Mean levels of Y170A-B1-V (n = 12) and
PMmut-B1-V (n = 28) in MI oocytes following in-
cubation in 100 nM nocodazole.
Error bars ± SEM throughout.
CDK1 Binding Protects Cyclin B1
from Destruction in Prometaphase
To demonstrate that CDK1 binding
protects cyclin B1 from destruction, we
altered the ratio of CDK1 to cyclin B1 by overexpressing CDK1.
We made use of kinase-dead CDK1 (Leroy et al., 1996) to allow
us to assess PMmotif masking independent of the prolonged in-
crease in CDK1 activity, which would be generated by adding
wild-type CDK1.
Prophase-arrested oocytes were injected with K33ACDK1-C
(cerulean labeled K33ACDK1) cRNA to generate CDK1 protein
levels in excess of cyclin B1 by 5.5 h post germinal vesicle break
down (GVBD). Oocytes were then allowed to mature after
receiving a second injection of either WT-B1-V or Y170A-B1-V
cRNA. Importantly, WT-B1-V and Y170A-B1-V fluorescence
increased at the same rate in K33ACDK1-C overexpressing
oocytes.
As expected, K33ACDK1 had a dominant-negative effect,
which resulted in delayed targeting of both fluorescent cyclin
B1 proteins and failure to extrude polar bodies. Critically, howev-
er, once targeted, the rate of Y170A-B1 protein destruction
was unperturbed in the presence of K33ACDK1-C (Figures 4C
and 4D). In contrast, WT-B1 destruction was significantly slower
in oocytes expressing K33ACDK1-C (Figures 4C and 4D).
Indeed, WT-B1-V levels failed to reach a minimum > 4 h after
Y170A-B1-V had undergone complete destruction. We would
not expect K33ACDK1-C to fully protect wild-type cyclin B1
since dynamic exchange ensures repetitive dissociation of
cyclin B1 from CDK1, periodically revealing the PM motif. How-
ever, in Y170A-B1, which cannot bind CDK1, the PM motif is
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always accessible, and accordingly, its destruction profile was
unperturbed. We reasoned that the profile of endogenous cyclin
B1 destruction would be like that of WT-B1-V, explaining why
K33ACDK1-C expressing oocytes were unable to extrude a PB.
In a further experiment, K33ACDK1-C expressing oocytes
received a second injection of PMmut-B1-V. Though PMmut-B1
protein was unable to bind CDK1 (due to the absence of
residues critical for CDK1 binding), this protein was not a destruc-
tion target and instead remained stable for a number of hours post
GVBD, despite possessing a D-box. This result was explained
using confocal microscopy, where we found that > 90% of all
K33ACDK1-C-expressing oocytes arrestedwithmisaligned chro-
mosomes and short immature spindles (data not shown). We
reasoned thatoocytesoverexpressingK33ACDK1-Cdonot reach
the stage of MI development at which D-box-only cyclin B1
destruction is initiated. We conclude that, prior to the establish-
ment of a metaphase spindle, the APC/C has a clear preference
for non-CDK1-bound cyclin B1 owing to the exposure of the
PMmotif.
Limiting the Excess of Cyclin B1 Results in Premature
MI Exit
Our data suggest the existence of a novel cyclin B1 motif that is
able to promote the destruction of an excess of non-CDK1-
bound cyclin B1 ahead of CDK1-bound cyclin B1. While this
mechanism has clear implications for our understanding of cell
cycle regulation in mouse oocytes, we wished to know whether
the excess of cyclin B1 plays an important role in oocyte biology.
To test this, we knocked down cyclin B1 levels (cyclin B1 MO;
Figure S4F) such that oocytes contained a 2-fold rather than
Figure 4. An Excess of Free Cyclin B1 Is Destroyed ahead of CDK1-Bound Cyclin B1; Therefore, Total Cyclin B1 Levels Do Not Reflect CDK1
Activity in MI Mouse
(A) Surface representation of cyclin B1:CDK1 from the crystal structure of its complex with CKS2 (pdb accession 4Y72); (Brown et al., 2015). The NTH and
preceding loop are excluded from the surface, and their backbones are instead shown (in blue), with residues 173-DIY-175 and 178-LRQL-181 highlighted in red.
The flexible N-terminal extension harboring the D-box is illustrated in a black dotted line.
(B) Mean destruction profiles of Y170A-B1-V and PMmut-B1-V alongside CDK1 activity determined using a FRET biosensor (n = 72). The decrease in spindle
checkpoint activity is illustrated in an orange gradient.
(C) Mean WT-B1-V (n = 18), Y170A-B1-V (n = 15), and PMmut-B1-V (n = 31) destruction traces following overexpression of K33ACDK1-C (kinase dead CDK1).
Control, non-K33ACDK1-C expressing destruction profiles are included as broken traces. Note that oocytes do not extrude polar bodies, presumably because of
a dominant-negative effect of K33ACDK1-C.
(D) Rates of WT-B1-V and Y170A-B1-V destruction measured as T1/2 in min in oocytes with and without K33ACDK1-C expression.
Error bars ± SEM throughout.
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6-fold excess of cyclin B1 at 5.5 h post GVBD (cyclin B1 MO
oocytes). Importantly, given that cyclin B1 still remained in
excess of CDK1, we observed no difference in the gradual
increase in CDK1 activity between control and cyclin B1 MO
oocytes. However, cyclin B1 MO oocytes then failed to maintain
a plateau of CDK1 activity and exited MI earlier (Figures 5A and
S6A). In addition, the D-box-B1 reporter was also destroyed
earlier in cyclin B1 MO oocytes (Figures 5B, S6B, and S6C),
strongly suggesting that early MI exit is due to premature
destruction of CDK1-bound cyclin B1 via the D-box. Given
this, it seemed plausible that depletion of the excess of cyclin
B1 in cyclin B1 MO oocytes reduced overall APCcdc20 substrate
competition, likely perturbing the destruction dynamics of other
cell cycle proteins. Indeed, we found that the APCcdc20 D-box
substrate securin was also targeted earlier in cyclin B1 MO
oocytes (Figure S6D).
Cyclin B1 MO oocytes attempted to extrude a PB1 40 min
earlier than control oocytes; however, the extruded body was
often enlarged and accompanied by excessive membrane bleb-
bing not normally seen in oocytes (Figures 5C–5F). This pheno-
type was not observed with a control 5-base-mismatch MO,
or if MO treated oocytes were subsequently rescued by microin-
jection of WT-B1-V (B1 MO + WT-B1), where chromosomes
condensed normally and segregated between the oocyte and
PB1 with normal morphology. In contrast, where PMmut-B1-V
was added back to B1 MO treated oocytes in place of WT-B1-V
(B1 MO + PMmut-B1), the MO phenotype was not rescued;
instead, 65% of oocytes arrested ahead of PB1 extrusion and
the remainder often still extruded an enlarged PB1 (Figure 5D).
To explore the cyclin B1 MO phenotype, control and cyclin B1
MO oocytes were injected with Map7-GFP (Bulinski et al., 1999)
cRNA and incubated in the DNA dye SiR-DNA to monitor micro-
tubules and chromosomes, respectively. Live fluorescence time-
lapse imaging was performed through multiple z-sections from
4 to 12 h post GVBD. Using this method, the majority of control
oocytes passed through MI with normal timing (83%). However,
in stark contrast, a number of grossly abnormal phenotypeswere
observed in dividing cyclin B1MOoocytes, including enlarged or
multiple polar bodies and failure of anaphase and/or cytokinesis
(Figures 6A and 6B; Video S1).
We reasoned that, because CDK1 activity was similar over the
first 5–6 h (Figure 5A), the spindles of cyclin B1 MO oocytes
would likely not differ from control oocytes at 5.5 h post GVBD.
Indeed, for all parameters measured (Figure 6C), no significant
differences were detected between control and cyclin B1 MO
groups at 5.5 h post GVBD (Figures 6D, S7A, S7C, and S7D;
Table 1). Furthermore, in agreement with prior work (Lane
et al., 2012; Kitajima et al., 2011; Sebestova et al., 2012), at
this time point, misaligned chromosomes were readily observed,
and the spindle had not yet fully migrated to the cortex, even
though cyclin B1 destruction was already underway. Subse-
quently, however, while control oocytes continued to align their
chromosomes and relocate their spindles, cyclin B1MO oocytes
failed to significantly reduce the area over which chromosomes
were dispersed, suggesting they were unable to promote further
chromosome congression (second plot, Figures 6D and S7C).
In addition, pre-anaphase measurements taken of spindle
length and spindle distance from the cortex were significantly
more varied in cyclin B1 MO oocytes than in control oocytes at
the same stage (Figures 6D and S7B–S7D; Table S1). Therefore,
inefficient spindle maintenance and misregulation of chromo-
some alignment due to the precocious loss of CDK1 activity in
late prometaphase appeared to be a direct result of a depleted
‘‘buffer’’ of cyclin B1.
DISCUSSION
Compared to prometaphase in mitosis, prometaphase I in
mammalian oocytes is an exceptionally long and complicated
process; pairs of homologous chromosomes must align on a bi-
polar spindle formed in the absence of functional centrosomes, a
process that involves multiple rounds of error correction, and
there are significant delays between each correction attempt
and a lengthy period of spindle migration (Clift and Schuh,
2015; Holubcova´ et al., 2015; Kitajima et al., 2011; Verlhac
et al., 2000). Even when a robust checkpoint is maximally acti-
vated in mitosis, its ability to delay exit is not indefinite, and
mitotic cells are still susceptible to ‘‘slippage’’ caused by slow
degradation of cyclin B1 (Brito and Rieder, 2006). Furthermore,
checkpoint signaling may be problematic in larger cells where
the ratio of kinetochores to cell volume is low (Galli and Morgan,
2016), a problem likely to be significant in an oocyte that is typi-
cally 300 times the volume of a mitotic cell. It is perhaps not
surprising that a few erroneous kinetochore-microtubule attach-
ments are not sufficient to inhibit anaphase in MI oocytes (Lane
et al., 2012; Sebestova et al., 2012; Gui and Homer, 2012;
Nagaoka et al., 2011).
As a result, cyclin B1:CDK1 activity is potentially vulnerable to
premature proteolysis for a number of hours in MI oocytes.
Indeed, in mouse oocytes, misaligned bivalents are a common
Figure 5. Restricting the Excess of Cyclin B1 Causes Premature D-box Only Mediated Destruction, Severely Compromising MI Division
(A) CDK1 activity in untreated (n = 72) and cyclin B1 MO injected oocytes (n = 64). Time 0 = PB1 extrusion in control oocytes while cyclin B1 MO oocytes extrude
aberrant PB1’s 40 min earlier as indicated. Upper x axis indicates timing post GVBD for the mean FRET trace within each treatment group.
(B) Mean destruction profile of D-box-B1-V in untreated (n = 20) and cyclin B1 MO oocytes (n = 31). GVBD to PB1 extrusion = 8 h and 5 min (± 5 min) in control
oocytes and 7 h and 24 min (± 11 min) in cyclin B1 MO oocytes.
(C) Representative images of (i) PB1 extrusion in a control oocyte and (ii) attempted PB1 extrusion in a cyclin B1 MO oocyte at times indicated post GVBD. For
comparison, the size of each PB1 was recorded as a proportion of the diameter of the oocyte prior to its extrusion (length of the yellow arrow as a percentage of
the blue arrow).
(D) PB1 size in control oocytes (green, n = 39), cyclin B1 MO oocytes (purple, n = 64), oocytes microinjected with a control cyclin B1 5-base-mismatch MO (B1
5-bpmmMO; gray, n = 20), and cyclin B1 MO oocytes subsequently rescued with WT-B1-V (yellow, n = 21). 5-base-mismatch MO oocytes and WT-B1-V rescue
oocytes divided normally and extruded PBs without the excessive blebbing noted in MO oocytes. The 5th box represents the size of the PB1 extruded in cyclin B1
MO oocytes subsequently injected with PMmut-B1-V (blue, n = 17). However, the majority of these oocytes (31/48) did not extrude a PB1 and instead arrested in
either metaphase or early anaphase. Error bars ± SEM throughout. *** denotes p value of < 0.001; ** denotes p value of < 0.005.
(E and F) Further examples of (E) a control oocyte and (F) cyclin B1 MO oocytes 8 h post GVBD (Hoechst DNA staining in red). Scale bar, 10 mm.
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feature up to 2 h after the initiation of cyclin B1 degradation (Lane
et al., 2012). High-resolution imaging determines an average of
two failed chromosome biorientation attempts per oocyte be-
tween 5 and 6 h post GVDB (Kitajima et al., 2011). We also often
find that chromosomes do not fully congress until 1 h before
anaphase when cyclin B1 is already depleted by >50% (Figures
1B, 1C, and S7E).
However, while this seemingly precocious destruction of cy-
clin B1 might appear detrimental, almost all chromosomes
achieve biorientation before anaphase, and the incidence of
aneuploidy in mouse oocytes is a mere 2%–4% (Lane et al.,
2012; Pan et al., 2008; Homer et al., 2005). Here, we provide a
model that resolves this puzzle by demonstrating that CDK1
activity is preserved in mouse oocytes despite the loss of cyclin
B1. Our results reveal that a surplus of free cyclin B1 exists, and
we propose that this acts as a protective buffer throughout the
prolonged duration of MI spindle assembly. This ensures that,
as the checkpoint begins to lose its inhibitory hold on the
APC/C, the degradation of cyclin B1 does not drop below the
level required to maintain CDK1 activity (Figure 6E).
As chromosomes align, and APC/Ccdc20 activity begins to
increase, an excess of cyclin B1 offers two advantages. First,
free cyclin B1 may provide a decoy substrate for the APC/C,
consistent with our finding that it is targeted in preference
to CDK1-bound cyclin B1 while the checkpoint is still active
(essentially acting as bait for the APC/C). Second, should
any CDK1-bound cyclin B1 become an early target for degra-
dation, sufficient surplus cyclin B1 is always available for
CDK1 reactivation. This capacity to reactivate CDK1 is also
likely critical because the relationship between cyclin B1 and
CDK1 is dynamic. The consequence is a prolonged inhibition
of anaphase and an extended prometaphase period that per-
mits chromosome alignment and error correction. Therefore,
though cyclin B1 destruction initiates in prometaphase, the
loss of CDK1 activity initiates 90 min later, closely coinciding
with the time at which stable end-on kinetochore-microtubule
attachments are formed and checkpoint proteins are maxi-
mally depleted from kinetochores (Kitajima et al., 2011; Lane
et al., 2012). Our results show that, without sufficient free
cyclin B1, the spindle checkpoint is unable to maintain prom-
etaphase CDK1 activity for long enough to prevent division
errors. Both the spindle checkpoint and an excess of cyclin
B1 contribute to the low frequency of aneuploidies in mouse
oocytes.
While our data demonstrate a requirement for excess cyclin
B1, the presence of such a surplus potentially presents a
Figure 6. Restricting Excess Cyclin B1 Results in Division Errors in Oocytes
(A) Bar chart representing the outcome of MI divisions in control and cyclin B1 MO oocytes following live confocal imaging of oocytes expressing Map7-GFP
(green) and SiR DNA (red). Oocytes were imaged every 15 min from 4 to 12 h post GVBD. Phenotype 1: DNA divides between the oocyte and a PB1 with normal
morphology. Phenotype 2: DNA divides between the oocyte and a PB1 that is outside of the range of PB1 sizes in control oocytes from the same oocyte pool.
Phenotype 3: the oocyte undergoes anaphase and cytokinesis; however, all DNA is extruded in 1 or more polar bodies. Phenotype 4: chromosomes appear to
align; however, anaphase is prevented. Phenotype 5: anaphase occurs yet cytokinesis fails, and attempted PBs are reabsorbed. Phenotype 6: ‘‘cut’’ phenotype;
cytokinesis takes place over unseparated chromosomes. Phenotype 7: DNA divides between the oocyte and a PB1 with normal morphology, yet chromosomes
do not align prior to anaphase.
(B) Example images of spindle movements and division phenotypes represented in (A). Phenotypes are also available to view as movies in Video S1. Scale
bar, 10 mm.
(C) Image representing spindle parameter measurements in live maturing control (n = 12) and cyclin B1 MO (n = 28) oocytes. As in Figures 5B and 5C, each
parameter was measured relative to oocyte size. ‘‘Chromosome dispersion’’ = the distance over which chromosomes are dispersed over the inter-polar axis.
‘‘Distance from the cortex’’ = distance from the cortex to the nearest spindle pole in the direction of spindle movement.
(D) Graphs showing changes in oocyte spindle parameters (as indicated) between 5.5 h post GVBD and ‘‘pre-anaphase’’ (the last image collected before
anaphase) in control (green, n = 12) and cyclin B1MOoocytes (purple, n = 28). Gray lines highlight paired datameasurements taken in the same oocyte. ** denotes
a significant difference in means (p < 0.005). Y denotes a significant difference between the variance of the control dataset and the variance of the cyclin B1 MO
dataset pre-anaphase. These data are also represented as boxplots in Figure S7. See Tables 1 and S1 for p values.
(E) Model of free cyclin B1 destruction ahead of CDK1-bound cyclin B1 destruction in MI mouse oocytes. As spindle checkpoint activity declines in late
prometaphase, an excess of free cyclin B1 is targeted for destruction via its D-box (black) and PM motif (red) in preference to CDK1-bound cyclin B1. CDK1-
bound cyclin B1 is initially preserved, targeted at a later time point via its D-box only, coinciding with more complete spindle checkpoint satisfaction and the
establishment of stable end-on kinetochore attachments.
Table 1. Significance of Differences in Variance and Means
between Control and Cyclin B1 MO Datasets
Independent Sample Comparisons between Control and Cyclin B1
MO Oocytes; Variance and Mean
Parameter Time Point
Variance
p Value
Mean
p Value
Spindle length 5.5 h post GVBD 0.059 0.248
Spindle width 5.5 h post GVBD 0.066 0.135
Chromosome
dispersion
5.5 h post GVBD 0.932 0.981
Spindle distance
from cortex
5.5 h post GVBD 0.110 0.893
Spindle length 15 min pre-anaphase 0.003 0.015
Spindle width 15 min pre-anaphase 0.285 0.984
Chromosome
dispersion
15 min pre-anaphase 0.016 0.004
Spindle distance
from cortex
15 min pre-anaphase 0.004 0.309
Control and cyclin B1 MO oocyte spindle lengths, widths, chromo-
some dispersion distances, and spindle cortex distances were judged
to be of equivalent variance at 5.5 h post GVBD. At this same time
point, mean values were not significantly different from one another.
At the later time point of 15 min prior to anaphase, no differences
were detected in spindle widths between control and cyclin B1 MO
oocytes. However, spindle lengths, chromosome dispersion distances,
and spindle cortex distances were significantly more varied in cyclin
B1 MO oocytes than in control oocytes. Furthermore, spindles were
significantly longer, and chromosomes were spread over a significantly
greater distance in cyclin B1 MO oocytes when compared to control
oocytes.
10 Developmental Cell 48, 1–13, March 11, 2019
Please cite this article in press as: Levasseur et al., Aneuploidy in Oocytes Is Prevented by Sustained CDK1 Activity through Degron Masking in Cyclin
B1, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.01.008
problem for the oocyte. Excessive amounts of APC/C substrate
are known to block the cell cycle, presumably as the APC/C can
be overwhelmed by many substrates in competition (Rape et al.,
2006). Cdc20 may not be in large excess over substrates (Lu
et al., 2015). Indeed, when the maintenance of the checkpoint
is prevented in early prometaphase, the resultant D-box-medi-
ated cyclin B1 degradation is slow (Figure 2B). The novel PM
motif we have identified may also explain how oocytes can over-
come this obstacle. The PM motif, only exposed when cyclin B1
is not bound to CDK1, not only provides an APC/C decoy but
also progressively removes the excess of cyclin B1 that might
otherwise later perturb MI exit. The metaphase drop in CDK1 ac-
tivity (necessary to drive anaphase) can then be readily achieved
by rapid D-box-mediated destruction of the smaller pool of
active CDK1-bound cyclin B1. This is evident in our B1 MO
‘‘rescue’’ experiments: when we replaced excess endogenous
cyclin B1 with WT-B1-V, we were able to rescue the B1 MO
phenotype. However, where PMmut-B1-V was used in place of
WT-B1-V, the majority of oocytes arrested in either metaphase
or early anaphase (Figure 5D).
How the PM motif allows free cyclin B1 to bypass the check-
point remains to be determined, though we would suggest that
our results mimic some aspects of cyclin A destruction. Timely
destruction of cyclin A in prometaphase is necessary for mitotic
exit and requires sequences outside of the canonical D-box
(Tin Su, 2001). The N terminus of cyclin A is able to bind Cdc20
with an affinity that may allow it to outcompete spindle check-
point proteins (Di Fiore and Pines, 2010). However, the rate of
cyclin A2 destructionmay still be reduced by highly active check-
point signaling (Boekhout and Wolthuis, 2015), presumably due
tomuchgreater competition forCdc20 fromcheckpoint proteins.
This suggests that the destruction of cyclin A2 remains at least
partially coupled to the activity of the checkpoint in early prome-
taphase. Likewise, Y170A-B1 and n190-B1 (both representing
free cyclin B1) show a reduced rate of destruction in a low con-
centration of nocodazole, which permits the assembly of a bipo-
lar spindle but blocks the cell cycle, presumably due to impaired
kinetochore-microtubule attachments (Wassmann et al., 2003).
This could suggest that PM-motif-mediated destruction of free
cyclin B1 might couple the timing of a prolonged prometaphase
to the progressive attachment status of chromosomes in MI
oocytes.
A major function of the ubiquitin-proteasome system is the
disposal of misfolded proteins (Fredrickson et al., 2011; Rose-
nbaum et al., 2011). Similarly, subunits of protein complexes
are often short lived if they do not become incorporated within
their complex (Davey and Morgan, 2016; Harper and Bennett,
2016; Ravid and Hochstrasser, 2008). This suggests that in
both situations, features that make proteins more susceptible
to degradation are exposed in specific states. An excellent
example of this is the S. pombe APC/C subunit Hcn1 and its
partner Cut9/Apc6. Crystallography shows the acetylated ‘‘N-
end rule’’ (Ac/N) degron of Hcn1 enclosed within Cut9 (Zhang
et al., 2010), consistent with the proposal that masking of Ac/
N degrons might control protein subunit stoichiometry (Hwang
et al., 2010). Indeed, overexpression of Cut9 and ‘‘decoy’’ Hcn1
proteins provided support for this model (Shemorry et al.,
2013). However, beyond such examples of protein quality con-
trol, there are few, if any, instances in which degron masking is
used to regulate the activity of a key protein complex. The PM
motif that we have identified clearly participates directly in the
heterodimerization interface in the recently solved structure of
cyclin B1 bound to CDK1 (Brown et al., 2015). Our results
suggest that oocytes exploit an imbalance in protein subunit
stoichiometry to maintain the activity of an essential cell cycle
regulator over a timescale of hours. We demonstrate that over-
expression of kinase-dead CDK1 protects cyclin B1, consistent
with the idea that the imbalance in levels of cyclin B1 and CDK1
is coupled to a degron-masking mechanism, allowing the
oocyte to overcome the unique set of challenges presented
by MI spindle assembly. Synthesis of an excess of cyclin B1
containing a prometaphase degradation motif generates a
decoy substrate, while the masking of this motif within the cy-
clin B1:CDK1 complex preserves essential CDK1 activity until
chromosome alignment is complete. We suggest that degron-
masking mechanisms may have more widespread functions
than previously anticipated.
In the current manuscript, we have revised our understanding
of the regulation of cyclin B1 and CDK1 activity in mouse
oocytes. Our findings are important for understanding chromo-
some segregation errors in human oocytes. Aneuploidy is the
number one genetic cause of miscarriage and birth defects in
humans (Hassold and Hunt, 2001). Even in women under the
age of 35, up to 30% of all zygotes are aneuploid, with 80–
90% of the errors thought to originate in oocyte MI (Homer,
2011). It is likely that the balance of cyclin B1 and CDK1 in hu-
man oocytes contributes to embryo viability. Furthermore,
given the general conservation of molecular mechanisms in
the control of both mitotic and meiotic cell cycles, it is possible
that the PMmotif has additional mitotic functions in the ‘‘house-
keeping’’ of cyclin B1 protein levels or the slippage of cells
out of mitotic arrest. Beyond cell division, it is likely that the
masking and unveiling of degrons has a key role to play in
proteostasis.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Gamete Collection and Culture
B Mitotic Cell Cultures
d METHOD DETAILS
B Preparation of cRNA Constructs for Microinjection
B Drug Treatments of Oocytes
B Knockdown of Gene Expression Using Morpholinos
B Microinjection and Imaging
B Molecular Structure Images
B Overexpression of Reporter Constructs
B Western Blotting
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Normalising Data in Individual Oocytes
B Data Alignment within Treatment Groups
B Data Alignment between Treatment Groups
B Methods of Statistical Analysis
Developmental Cell 48, 1–13, March 11, 2019 11
Please cite this article in press as: Levasseur et al., Aneuploidy in Oocytes Is Prevented by Sustained CDK1 Activity through Degron Masking in Cyclin
B1, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.01.008
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and one video
and can be found with this article online at https://doi.org/10.1016/j.devcel.
2019.01.008.
ACKNOWLEDGMENTS
We thank M. Herbert and J.A. Endicott for critical reading of the manuscript
and M. Sinclair and F. Davidson for technical assistance. This work was sup-
ported by a Wellcome Trust Career Re-entry Fellowship grant to S.M.
(062376). J.M.G.H. is a Wellcome Trust Investigator (106951/Z/15/Z), was a
Scholar of the Leukemia and Lymphoma Society (1028-12), and holds a Royal
Society Wolfson Research Merit Award. O.R.D. is a Sir Henry Dale Fellow
jointly funded by the Wellcome Trust and Royal Society (Grant Number
104158/Z/14/Z).
AUTHOR CONTRIBUTIONS
S.M. was responsible for the overall direction of the project. S.M. carried out
most of the experiments alongside C.T. and M.D.L. S.M. and M.D.L. designed
most of the experiments alongside J.M.G.H., and O.R.D., S.M., J.M.G.H.,
M.D.L., and C.T. prepared the manuscript.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: May 17, 2018
Revised: October 22, 2018
Accepted: December 29, 2018
Published: February 7, 2019
REFERENCES
Arooz, T., Yam, C.H., Siu, W.Y., Lau, A., Li, K.K.W., and Poon, R.Y.C. (2000).
On the concentrations of cyclins and cyclin-dependent kinases in extracts of
cultured human cells. Biochemistry 39, 9494–9501.
Bentley, A.M., Normand, G., Hoyt, J., and King, R.W. (2007). Distinct sequence
elements of cyclin B1 promote localization to chromatin, centrosomes, and
kinetochores during mitosis. Mol. Biol. Cell 18, 4847–4858.
Boekhout, M., and Wolthuis, R. (2015). Nek2A destruction marks APC/C acti-
vation at the prophase-to-prometaphase transition by spindle-checkpoint-
restricted Cdc20. J. Cell Sci. 128, 1639–1653.
Brito, D.A., and Rieder, C.L. (2006). Mitotic checkpoint slippage in humans oc-
curs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol.
16, 1194–1200.
Brown, N.R., Korolchuk, S., Martin, M.P., Stanley, W.A., Moukhametzianov,
R., Noble, M.E.M., and Endicott, J.A. (2015). CDK1 structures reveal
conserved and unique features of the essential cell cycle CDK. Nat.
Commun. 6, 6769.
Brunet, S., Maria, A.S., Guillaud, P., Dujardin, D., Kubiak, J.Z., and Maro, B.
(1999). Kinetochore fibers are not involved in the formation of the first meiotic
spindle in mouse oocytes, but control the exit from the first meiotic M phase.
J. Cell Biol. 146, 1–12.
Bulinski, J.C., Gruber, D., Faire, K., Prasad, P., and Chang,W. (1999). GFP chi-
meras of E-MAP-115 (ensconsin) domains mimic behavior of the endogenous
protein in vitro and in vivo. Cell Struct. Funct. 24, 313–320.
Clift, D., and Schuh, M. (2015). A three-step MTOC fragmentation mechanism
facilitates bipolar spindle assembly in mouse oocytes. Nat. Commun. 6, 7217.
Clute, P., and Pines, J. (1999). Temporal and spatial control of cyclin B1
destruction in metaphase. Nat. Cell Biol. 1, 82–87.
Davey, N.E., andMorgan, D.O. (2016). Building a regulatory network with short
linear sequence motifs: lessons from the degrons of the anaphase-promoting
complex. Mol. Cell 64, 12–23.
Davydenko, O., Schultz, R.M., and Lampson, M.A. (2013). Increased CDK1
activity determines the timing of kinetochore-microtubule attachments in
meiosis I. J. Cell Biol. 202, 221–229.
Di Fiore, B., and Pines, J. (2010). How cyclin A destruction escapes the spindle
assembly checkpoint. J. Cell Biol. 190, 501–509.
Fredrickson, E.K., Rosenbaum, J.C., Locke, M.N., Milac, T.I., and Gardner,
R.G. (2011). Exposed hydrophobicity is a key determinant of nuclear quality
control degradation. Mol. Biol. Cell 22, 2384–2395.
Galli, M., and Morgan, D.O. (2016). Cell size determines the strength of the
spindle assembly checkpoint during embryonic development. Dev. Cell 36,
344–352.
Gavet, O., and Pines, J. (2010). Progressive activation of CyclinB1-Cdk1 coor-
dinates entry to mitosis. Dev. Cell 18, 533–543.
Glotzer, M., Murray, A.W., and Kirschner, M.W. (1991). Cyclin is degraded by
the ubiquitin pathway. Nature 349, 132–138.
Goda, T., Funakoshi, M., Suhara, H., Nishimoto, T., and Kobayashi, H. (2001).
The N-terminal helix of Xenopus cyclins A and B contributes to binding spec-
ificity of the cyclin-CDK complex. J. Biol. Chem. 276, 15415–15422.
Gorbsky, G.J. (2015). The spindle checkpoint and chromosome segregation in
meiosis. FEBS J. 282, 2471–2487.
Guharoy, M., Bhowmick, P., Sallam, M., and Tompa, P. (2016). Tripartite
degrons confer diversity and specificity on regulated protein degradation in
the ubiquitin-proteasome system. Nat. Commun. 7, 10239.
Gui, L., and Homer, H. (2012). Spindle assembly checkpoint signalling is
uncoupled from chromosomal position in mouse oocytes. Development 139,
1941–1946.
Hagting, A., Den Elzen, N., Vodermaier, H.C., Waizenegger, I.C., Peters, J.M.,
and Pines, J. (2002). Human securin proteolysis is controlled by the spindle
checkpoint and reveals when the APC/C switches from activation by Cdc20
to Cdh1. J. Cell Biol. 157, 1125–1137.
Harper, J.W., and Bennett, E.J. (2016). Proteome complexity and the forces
that drive proteome imbalance. Nature 537, 328–338.
Hassold, T., and Hunt, P. (2001). To err (meiotically) is human: the genesis of
human aneuploidy. Nat. Rev. Genet. 2, 280–291.
He, J., Chao, W.C.H., Zhang, Z., Yang, J., Cronin, N., and Barford, D. (2013).
Insights into degron recognition by APC/C coactivators from the structure of
an Acm1-Cdh1 complex. Mol. Cell 50, 649–660.
Herbert, M., Levasseur, M., Homer, H., Yallop, K., Murdoch, A., and
Mcdougall, A. (2003). Homologue disjunction in mouse oocytes requires
proteolysis of securin and cyclin B1. Nat. Cell Biol. 5, 1023–1025.
Holubcova´, Z., Blayney, M., Elder, K., and Schuh, M. (2015). Human oocytes.
Error-prone chromosome-mediated spindle assembly favors chromosome
segregation defects in human oocytes. Science 348, 1143–1147.
Homer, H. (2011). New insights into the genetic regulation of homologue
disjunction in mammalian oocytes. Cytogenet. Genome Res. 133, 209–222.
Homer, H.A., Mcdougall, A., Levasseur, M., Yallop, K., Murdoch, A.P., and
Herbert, M. (2005). Mad2 prevents aneuploidy and premature proteolysis of
cyclin B and securin during meiosis I in mouse oocytes. Genes Dev. 19,
202–207.
Hwang, C.S., Shemorry, A., and Varshavsky, A. (2010). N-terminal acetylation
of cellular proteins creates specific degradation signals. Science 327,
973–977.
Izawa, D., and Pines, J. (2011). How APC/C-Cdc20 changes its substrate
specificity in mitosis. Nat. Cell Biol. 13, 223–233.
Kitajima, T.S., Ohsugi, M., and Ellenberg, J. (2011). Complete kinetochore
tracking reveals error-prone homologous chromosome biorientation in
mammalian oocytes. Cell 146, 568–581.
Kolano, A., Brunet, S., Silk, A.D., Cleveland, D.W., and Verlhac, M.H. (2012).
Error-prone mammalian female meiosis from silencing the spindle assembly
checkpoint without normal interkinetochore tension. Proc. Natl. Acad. Sci.
U S A 109, E1858–E1867.
12 Developmental Cell 48, 1–13, March 11, 2019
Please cite this article in press as: Levasseur et al., Aneuploidy in Oocytes Is Prevented by Sustained CDK1 Activity through Degron Masking in Cyclin
B1, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.01.008
Lane, S.I.R., and Jones, K.T. (2014). Non-canonical function of spindle assem-
bly checkpoint proteins after APC activation reduces aneuploidy in mouse
oocytes. Nat. Commun. 5, 3444.
Lane, S.I.R., Yun, Y., and Jones, K.T. (2012). Timing of anaphase-promoting
complex activation in mouse oocytes is predicted by microtubule-kinetochore
attachment but not by bivalent alignment or tension. Development 139,
1947–1955.
Lara-Gonzalez, P., Westhorpe, F.G., and Taylor, S.S. (2012). The spindle
assembly checkpoint. Curr. Biol. 22, R966–R980.
Ledan, E., Polanski, Z., Terret, M.E., andMaro, B. (2001). Meiotic maturation of
the mouse oocyte requires an equilibrium between cyclin B synthesis and
degradation. Dev. Biol. 232, 400–413.
Lemaire, P., Garrett, N., and Gurdon, J.B. (1995). Expression cloning of
Siamois, a Xenopus homeobox gene expressed in dorsal-vegetal cells of blas-
tulae and able to induce a complete secondary axis. Cell 81, 85–94.
Leroy, D., Birck, C., Brambilla, P., Samama, J.P., and Ducommun, B. (1996).
Characterisation of human cdc2 lysine 33 mutations expressed in the fission
yeast Schizosaccharomyces pombe. FEBS Lett. 379, 217–221.
Levasseur, M. (2013). Making cRNA for microinjection and expression of fluo-
rescently tagged proteins for live-cell imaging in oocytes. In Mammalian
Oocyte Regulation: Methods and Protocols, H.A. Homer, ed. (Humana
Press), pp. 121–134.
Levasseur, M., Dumollard, R., Chambon, J.P., Hebras, C., Sinclair, M.,
Whitaker, M., andMcdougall, A. (2013). Release frommeiotic arrest in ascidian
eggs requires the activity of two phosphatases but not CaMKII. Development
140, 4583–4593.
Lu, D., Girard, J.R., Li, W., Mizrak, A., and Morgan, D.O. (2015). Quantitative
framework for ordered degradation of APC/C substrates. BMC Biol. 13, 96.
Madgwick, S., Hansen, D.V., Levasseur, M., Jackson, P.K., and Jones, K.T.
(2006). Mouse Emi2 is required to enter meiosis II by reestablishing cyclin
B1 during interkinesis. J. Cell Biol. 174, 791–801.
Madgwick, S., Nixon, V.L., Chang, H.Y., Herbert, M., Levasseur, M., and
Jones, K.T. (2004). Maintenance of sister chromatid attachment in mouse
eggs through maturation-promoting factor activity. Dev. Biol. 275, 68–81.
Nagaoka, S.I., Hodges, C.A., Albertini, D.F., and Hunt, P.A. (2011). Oocyte-
specific differences in cell-cycle control create an innate susceptibility to
meiotic errors. Curr. Biol. 21, 651–657.
Nixon, V.L., Levasseur, M., Mcdougall, A., and Jones, K.T. (2002). Ca(2+)
oscillations promote APC/C-dependent cyclin B1 degradation during meta-
phase arrest and completion of meiosis in fertilizing mouse eggs. Curr. Biol.
12, 746–750.
Pan, H., Ma, P., Zhu, W., and Schultz, R.M. (2008). Age-associated increase in
aneuploidy and changes in gene expression in mouse eggs. Dev. Biol. 316,
397–407.
Pines, J. (2011). Cubism and the cell cycle: the many faces of the APC/C. Nat.
Rev. Mol. Cell Biol. 12, 427–438.
Prodon, F., Chenevert, J., He´bras, C., Dumollard, R., Faure, E., Gonzalez-
Garcia, J., Nishida, H., Sardet, C., and Mcdougall, A. (2010). Dual mechanism
controls asymmetric spindle position in ascidian germ cell precursors.
Development 137, 2011–2021.
Rape, M., Reddy, S.K., and Kirschner, M.W. (2006). The processivity of multi-
ubiquitination by the APC determines the order of substrate degradation. Cell
124, 89–103.
Ravid, T., and Hochstrasser, M. (2008). Diversity of degradation signals in the
ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 9, 679–690.
Reis, A., Madgwick, S., Chang, H.Y., Nabti, I., Levasseur, M., and Jones, K.T.
(2007). Prometaphase APCcdh1 activity prevents non-disjunction in mamma-
lian oocytes. Nat. Cell Biol. 9, 1192–1198.
Rosenbaum, J.C., Fredrickson, E.K., Oeser, M.L., Garrett-Engele, C.M.,
Locke, M.N., Richardson, L.A., Nelson, Z.W., Hetrick, E.D., Milac, T.I.,
Gottschling, D.E., et al. (2011). Disorder targets misorder in nuclear quality
control degradation: a disordered ubiquitin ligase directly recognizes its
misfolded substrates. Mol. Cell 41, 93–106.
Santamarı´a, D., Barrie`re, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K.,
Ca´ceres, J.F., Dubus, P., Malumbres, M., and Barbacid, M. (2007). Cdk1 is
sufficient to drive the mammalian cell cycle. Nature 448, 811–815.
Sebestova, J., Danylevska, A., Novakova, L., Kubelka, M., and Anger, M.
(2012). Lack of response to unaligned chromosomes in mammalian female
gametes. Cell Cycle 11, 3011–3018.
Shemorry, A., Hwang, C.S., and Varshavsky, A. (2013). Control of protein qual-
ity and stoichiometries by N-terminal acetylation and the N-end rule pathway.
Mol. Cell 50, 540–551.
Solc, P., Kitajima, T.S., Yoshida, S., Brzakova, A., Kaido, M., Baran, V., Mayer,
A., Samalova, P., Motlik, J., and Ellenberg, J. (2015). Multiple requirements of
PLK1 during mouse oocyte maturation. PLoS One 10, e0116783.
Sullivan, M., and Morgan, D.O. (2007). Finishing mitosis, one step at a time.
Nat. Rev. Mol. Cell Biol. 8, 894–903.
Tin Su, T. (2001). Cell cycle: how, when and why cells get rid of cyclin A. Curr.
Biol. 11, R467–R469.
Todaro, G.J., and Green, H. (1963). Quantitative studies of the growth of
mouse embryo cells in culture and their development into established lines.
J. Cell Biol. 17, 299–313.
Varshavsky, A. (1991). Naming a targeting signal. Cell 64, 13–15.
Verlhac, M.H., Lefebvre, C., Guillaud, P., Rassinier, P., and Maro, B. (2000).
Asymmetric division in mouse oocytes: with or without Mos. Curr. Biol. 10,
1303–1306.
Wassmann, K., Niault, T., and Maro, B. (2003). Metaphase I arrest upon acti-
vation of the Mad2-dependent spindle checkpoint in mouse oocytes. Curr.
Biol. 13, 1596–1608.
Wolthuis, R., Clay-Farrace, L., Van Zon, W., Yekezare, M., Koop, L., Ogink, J.,
Medema, R., and Pines, J. (2008). Cdc20 and Cks direct the spindle check-
point-independent destruction of cyclin A. Mol. Cell 30, 290–302.
Yamano, H., Tsurumi, C., Gannon, J., and Hunt, T. (1998). The role of the
destruction box and its neighbouring lysine residues in cyclin B for anaphase
ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor.
EMBO J. 17, 5670–5678.
Zhang, Z., Kulkarni, K., Hanrahan, S.J., Thompson, A.J., and Barford, D.
(2010). The APC/C subunit Cdc16/Cut9 is a contiguous tetratricopeptide
repeat superhelix with a homo-dimer interface similar to Cdc27. EMBO J.
29, 3733–3744.
van Zon, W.V., and Wolthuis, R.M.F. (2010). Cyclin A and Nek2A: APC/C–
Cdc20 substrates invisible to the mitotic spindle checkpoint. Biochem. Soc.
Trans. 38, 72–77.
Developmental Cell 48, 1–13, March 11, 2019 13
Please cite this article in press as: Levasseur et al., Aneuploidy in Oocytes Is Prevented by Sustained CDK1 Activity through Degron Masking in Cyclin
B1, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.01.008
STAR+METHODS
KEY RESOURCES TABLE
REAGENT OR RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-cyclin B1 Abcam Cat# ab72 [V152]
RRID:AB_305751
Anti-CDK1/CDK2 Santa Cruz Cat# sc-53219 [AN21.2]
RRID:AB_2120095
Anti–mouse IgG Cell Signaling Technology Cat# 7076P2, RRID:AB_330924
Bacterial and Virus Strains
Cdk1 FRET Sensor (2372) Addgene (Gavet and Pines, 2010) RRID:Addgene_26064
Inactive Cdk1 FRET Sensor (2328) Gift from Jonathan Pines (Gavet and Pines, 2010) RRID:Addgene_26065
K33ACDK1 Gift from Jonathan Pines N/A
Unmodified pRN3 vector A gift from Patrick Lemaire (Lemaire et al., 1995) N/A
Modified pRN3 vector Levasseur, 2013 N/A
Chemicals, Peptides, and Recombinant Proteins
M2 medium Sigma Cat# M7167
MDL# MFCD00283761
3-isobutyl-1-methylxanthine Sigma Cat# I5879
CAS# 28822-58-4
Nocodazole Sigma Cat# M1404
CAS# 31430-18-9
Flavopiridol Santa Cruz Cat# sc-202157
CAS# 146426-40-6
Reversine Sigma Cat# R3904
Cas# 656820-32-5
Cycloheximide Sigma Cat# 01810
Cas# 66-81-9
Hoechst 33342 Sigma Cat# 14533
Cas# 23491-52-3
SiR-DNA Spirochrome Cat# CHF280.00
DMEM media Lonza Cat# 12-604
Fetal Bovine Serum Gibco Cat# 16000044
Recombinant CDK1 protein A gift from Jane Endicott (Brown et al., 2015) N/A
CDK1/Cyclin B Recombinant Human Protein Thermo Fisher PV3292
Critical Commercial Assays
T3 mMESSAGE mMACHINE Ambion Cat# AM1348
GeneEditor Promega Cat# Q9280
ECL Select detection reagents GE Healthcare Cat# RPN2235
Experimental Models: Cell Lines
U2OS cells A gift from Neil Perkins (RRID:CVCL_0042)
MEF cells A gift from Neil Perkins N/A
Experimental Models: Organisms/Strains
Oocytes from 4-8 week old CD1 mice Charles River IMSR Cat# CRL:22, RRID:
IMSR_CRL:22
Oligonucleotides
Human cyclin B1 primers (Genbank: NM_031966) Life Technologies N/A
Human securin primers (Genbank: AJ223953.1) Life Technologies N/A
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Suzanne
Madgwick (suzanne.madgwick@newcastle.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Gamete Collection and Culture
4 to 8-week-old female, outbred, CD1 mice (Charles River; RRID:IMSR_CRL:22) were used. All animals were handled in accordance
with ethics approved by the UK Home Office Animals (Scientific Procedures) Act 1986. GV oocytes were collected from ovaries
punctured with a sterile needle; oocytes were stripped of their cumulus cells mechanically using a pipette. For bench
handling, microinjections, and imaging experiments, oocytes were cultured at 37C in medium M2 (Sigma), with the addition of
30 nM 3-isobutyl-1-methylxanthine (IBMX; Sigma) to arrest oocytes at prophase I where necessary. Data was only collected from
oocytes which underwent GVBD with normal timings and had a diameter within 95-105% of the population average. To ensure
reproducibility, oocyte data sets were gathered from a minimum of 3 independent experiments. For each independent experiment
both control and treatments groups were derived from the same pool of oocytes collected from a minimum of 2 animals. Oocytes
were selected at random for microinjection, however the investigators were not blinded to allocation during experiments or outcome
assessment.
Mitotic Cell Cultures
U2OS cells (an immortalised cell line from a female patient with osteosarcoma; RRID:CVCL_0042) andMouse Embryonic Fibroblasts
(MEFs) were used as western blotting standards and were a gift from Neil Perkins. The sex of the embryonic mice for the MEF
cells was not determined as this was not procedure at the time. U2OS cells were maintained at 37C, 5% CO2 in DMEM (Lonza)
with 10%FBS (Life Technologies) and antibiotics. While U2OS cells are a standard laboratory cell line, MEFswere isolated as follows;
internal torso connective tissue from 13.5-day embryos was washed in sterile PBS andminced in 1x Trypsin (Invitrogen) for 15 min at
37C. The sex of the embryonic mice was not determined. Following repeated pipetting to break up large tissue fragments, the
cell pellet was resuspended in DMEM (Lonza) supplemented with 20% Fetal Bovine Serum (FBS) (Gibco, Paisley, UK) and
50U/ml penicillin/streptomycin (Lonza), and incubated at 37C in a 5% CO2 humidified atmosphere. Once cells reached 90%
confluency, they were sub-cultured in 75cm2 flasks and considered as passage 1. Cells were then cultured following the standard
3T3 protocol (Todaro and Green, 1963). Cells were considered immortalised beyond passage 14, but not used in experiments
beyond passage 25.
Continued
REAGENT OR RESOURCE SOURCE IDENTIFIER
Human K33ACDK1 primers (UGID:5796252) Life Technologies N/A
APC3 MO
CTTGAGGCTCAGACCCACTTTCTGC
Gene Tools N/A
APC3 MO 5-base-mismatch
CTTCACGCTGAGACCCACTTTGTCC
Gene Tools N/A
Cdc20 MO
CGCTCTCGAACACGAACTGCGCCAT
Gene Tools N/A
Cyclin B1 MO
TGTTCCTAGTGACCCTGAGCGCCAT
Gene Tools N/A
Cyclin B1 MO 5-base-mismatch
TCTTCCTACTGAACCTGACCGCAAT
Gene Tools N/A
Software and Algorithms
Metafluor 7.7.0.0 Molecular Devices RRID:SCR_014294
NIS Elements AR version 5.02.01 Nikon RRID:SCR_014329
Image J Image J RRID:SCR_003070
SPSS IBM RRID:SCR_002865
PyMOL Molecular Graphics System Version 1.3 Schro¨dinger, LLC RRID:SCR_000305
Other
Inverted epifluorescence microscope Olympus Cat# 1X71
Confocal laser microscope Nikon Cat# A1R
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METHOD DETAILS
Preparation of cRNA Constructs for Microinjection
The Y170A mutant of cyclin B1 was made using the GeneEditor (Promega) in vitro mutagenesis system according to the manufac-
turer’s protocol. Microtubules were visualised by expression of mRNA coding for themicrotubule binding protein Map7 fused to GFP
(Prodon et al., 2010). Wild type human cyclin B1 (NM_031966), human securin (AF095287.1) and human CDK1 K33A (a gift from Jon-
athon Pines) sequences were amplified by PCR as previously described (Madgwick et al., 2004). Further cyclin B1 mutations were
generated by primer overhang extension PCR. D90 cyclin B1 was cloned into a pRN3 vector (a gift from Patrick Lamaire; (Lemaire
et al., 1995) while all other amplified sequences were cloned into a modified pRN3 vector designed to produce mRNA transcripts
C-terminally coupled to Venus or Cerulean fluorescent proteins (Levasseur, 2013). The CDK1 FRET sensor (Addgene plasmid
#26064) and inactive sensor (a gift from Jonathon Pines) sequences were amplified by PCR and cloned into the pRN3 vector.
Maximal stability was conferred on all cRNA constructs by the presence of a 50 globin UTR upstream and both 30UTR and poly
(A)–encoding tracts downstream of the gene. cRNA for microinjection was synthesized using T3 mMESSAGE mMACHINE (Ambion)
and dissolved in nuclease-free water to the required micropipette concentration.
Drug Treatments of Oocytes
At the times indicated, nocodazole (Sigma) was added to media at a concentration of either 100 or 500 nM, the CDK1 inhibitor fla-
vopiridol (Santa Cruz) at 1 mM (Solc et al., 2015), the Mps1 inhibitor reversine (Sigma) at 100 nM (Kolano et al., 2012) and the protein
synthesis inhibitor cycloheximide (Sigma) at 10 mg/ml (Madgwick et al., 2006). Where used, Hoechst 33342 at 10 mg/ml (Sigma) was
added to media for 15 min prior to imaging. For longer term confocal time-lapse imaging, DNA was stained with SiR-DNA at 250 nM
(Spirochrome).
Knockdown of Gene Expression Using Morpholinos
Morpholino antisense oligos (MO; Genetools) designed to recognize the 50UTRof cyclin B1, Cdc20 and APC3weremicroinjected at a
micropipette concentration of 1 mM. Cyclin B1 MO and cyclin B1 5 base pair mismatch (5bpmm) MO oocytes were released from
arrest within 30 minutes of injection since we did not want to perturb prophase levels of cyclin B1, but only to prevent such excessive
accumulation in prometaphase. APC3 MO and APC3 5bpmmMO injected oocytes were arrested in prophase with IBMX for 6 hours
prior to release. A short Cdc20MO incubation period (1.5-2 hours) was carried out as previously described (Reis et al., 2007). A longer
Cdc20 MO incubation period required the use of cycloheximide since oocytes began to escape IBMX induced prophase arrest
approximately 3 hours after injection of the Cdc20 MO. We reasoned that, without sufficient Cdc20 available to suppress prometa-
phase cyclin B1 levels, a premature increase in cyclin B1 drove oocytes out of prophase. Therefore, a longer Cdc20 MO incubation
period included cycloheximide to prevent this. To release prophase arrest, both IBMX and cycloheximide were washed out from
oocyte containingmedia; the use of cycloheximide in prophase arrest did not perturb subsequentMImaturation or cyclin B1 destruc-
tion profiles in control oocytes.
Microinjection and Imaging
Oocyte microinjection of MOs and cRNA constructs was carried out on the heated stage of an inverted epifluorescence microscope
(Olympus; 1X71). In brief, fabricated micropipettes were inserted into cells using the negative capacitance overcompensation facility
on an electrophysiological amplifier (World Precision Instruments); this procedure ensures a high rate of survival (>95%). For destruc-
tion profiles, images were captured on an Olympus IX71 inverted epifluorescencemicroscope using a CCD camera (Micromax, Sony
Interline chip, Princeton Instruments), analysed and processed using MetaFluor software (version 7.7.0.0; Molecular Devices). All ex-
periments were performed at 37C. To generate fluorescent protein profiles, bright-field and fluorescence images were recorded at
10minute intervals. Confocal images were collected on aNikon A1R confocal lasermicroscope. Imaging began4 hours post GVBD
to minimise oocyte laser exposure. Oocytes were imaged at 15 minute intervals through 15+ Z-sections over an 8-hour period in a
temperature-controlled, humidified chamber at 37C. Fluorescent images were recorded and processed in NIS-Elements (Nikon).
Molecular Structure Images
Molecular structure images were generated using the PyMOL Molecular Graphics System, Version 1.3 Schro¨dinger, LLC.
Overexpression of Reporter Constructs
The maximum level of expression of all non-CDK1 binding cyclin B1 reporter constructs was kept low (8-13% of endogenous; Fig-
ure S1G) and did not perturb meiosis I progression as determined by identical mean GVBD and PB1 extrusion timings (compared to
uninjected oocytes from the same pool), and by recording the timing of the establishment of a barrel shaped spindle by time lapse
microscopy. Hence, where oocytes are aligned at PB1, themeanGVBD to PB1 timings between groups are always identical. All com-
parisons only include data from oocytes expressing cyclin B1 constructs to similar levels (see Figure S3A for example). Given the 1:1
ratio of the cyclin B1 to FP component of each construct, we reasoned that comparable fluorescence levels equate to comparable
molar amounts. Oocytes with either excessive starting amounts of reporter proteins, or with excessive translation rates were dis-
counted. Where cyclin B1 constructs were not used to report destruction timing; D90 cyclin B1 in Figure S5, and WT-B1-V in MO
‘rescue’ experiments (Figure 5D); cRNA was injected to generate expression at 80% endogenous relative to a control oocyte.
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Western Blotting
Mitotic cells were prepared by lysis in Laemmli buffer following mechanical shake off of mitotic cells after 8 h incubation in 100 nM
nocodazole. Oocytes were collected 5.5 hours after GVBD ± 15 min and lysed in Laemmli buffer. The cyclin B1:CDK1 purified
complex was purchased from Thermo Fisher Scientific; PV3292. SDS-PAGE and immunoblotting was conducted by standard
procedures. For cyclin B1, immunoblots were incubated for 2 hours with anti-cyclin B1 (Abcam ab72) at 1:250. For CDK1, immuno-
blots were incubated for 2 hours with anti-CDK1/CDK2 (Santa Cruz sc-53219) at 1:200. Non-fat milk (5%) was used as a blocking
solution. Anti–mouse IgG (7076P2; Cell Signaling) and ECL Select (RPN2235; GE Healthcare) were used as secondary detection
reagents. ECL Select detection reagents were specifically used to produce x-ray signals with broad linear dynamic range. The
intensity of each band was then determined in Image-J after scanning x-ray film. Band intensities were plotted against oocyte
numbers in Excel. The equation of the line generated by these points was used to determine the relative amount in cyclin B1 MO
oocytes. Note in Figure S4F, the band intensity of the cyclin B1 MO oocyte lane is within our standard curve. Immunoblots
S1A + D are representative of 3 independent blots. Immunoblot S1F is representative of 2 independent blots.
QUANTIFICATION AND STATISTICAL ANALYSIS
All relevant data are available from the authors. Where fluorescence values are used to generate destruction profiles, each curve
represents the mean set of values recorded from a number of oocytes (n = stated in figure legends). As stated within figure legends,
error bars = SEM throughout. The extent of the effect of mutating and truncating cyclin B1 on subsequent destruction timings was not
pre-specified therefore no statistical method was used to predetermine sample size.
Normalising Data in Individual Oocytes
In the majority of experiments, where fluorescent proteins displayed a period of destruction, the peak fluorescence value prior
to destruction was normalised to 100 au. Where a treatment did not result in a period of destruction (Figures 2A, 2C, 2D, 3D,
and 4C), values were instead normalised to 50 au at GVBD (reflecting the fact that cyclin B1 construct fluorescence typically
doubled in intensity from GVBD to its maximum). Similarly, where the CDK1 FRET sensor showed a loss of FRET signal, the
peak signal prior to the drop was normalised to 100 au. On two occasions treatment did not result in a loss of FRET signal (Fig-
ure S5; D90 cyclin B1 and inactive FRET sensor traces). D90 cyclin B1 values were instead normalised to 90 au at GVBD reflecting
the fact that the FRET signal typically increased by 10% fromGVDB to itsmaximum. Inactive FRET valueswere instead normalised to
75 au at GVBD reflecting the fact that the inactive FRET ratio was typically 75% of the maximum active FRET signal in late
prometaphase oocytes.
Data was normalised in order to give each fluorescence profile the same importance regardless of starting or maximum fluores-
cence value. However, like examples in Figures S3A, S3B, S6A, and S6B, we also compared mean traces generated by raw data
(aligned to both GVBD and PB1). As expected, in each case, while raw data figures are naturally more variable at individual time
points, the order of construct destruction remains the same.
Data Alignment within Treatment Groups
Where the focus of the experiment was to determine the length of the destruction period prior PB1 extrusion, fluorescence curves
from individual oocytes were aligned at the point of PB1 extrusion.Where determining the effect of a drug was the focus of the exper-
iment, fluorescence curveswere aligned at the point of drug addition.Where treatment did not result in either a loss of fluorescence or
PB1 extrusion, fluorescence traces were aligned at GVBD. Means for each treatment group at each time point were then calculated.
Error bars equal S.E.M throughout.
Data Alignment between Treatment Groups
For comparison, where the fluorescence traces fromdifferent types of treatment are shown alongside each other (Figures 2A, 2C, 2D,
4C, 5A, 5B, and S5) mean fluorescence curves are aligned by matching mean GVBD time points.
Methods of Statistical Analysis
In Figure 4D destruction rates were expressed as T1/2 values in minutes, calculated using the formula T1/2=ln(0.5)/k, where k=-1/T3
ln (t1/t2), where T is the time interval between t1 and t2, and where t1 and t2 are the start and finish fluorescence values (Levasseur
et al., 2013). Statistical comparison of destruction rates of mean T1/2 values was by two-sample two-tailed t-test; a null hypothesis
was rejected if P<0.05.
Spindle parameter measurements were recorded in NIS-Elements (Nikon) after confocal imagining. To determine the most appro-
priate statistical test for data analysis, data sets were first checked for distribution type. By ‘Shapiro-Wilk’ testing, spindle lengths,
spindle widths and chromosome dispersion distances were judged to be normally distributed. Spindle distances from the cortex and
PB1 sizes were not judged to be normally distributed. All tests were performed in SPSS.
Table 1; for non-paired data sets where data sets were judged to be normally distributed, ‘Levene’s Test’ was carried out to judged
equality of variances. Once it was determined whether equal variance could or could not be assumed, the relevant ‘Independent
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Samples Test’ 2-tailed P-value determined the significance of differences betweenmeans. For non-paired data sets where data sets
were not judged to be normally distributed (PB1 size), non-parametric ‘Mann-Whitney U Tests’ were used to determine the signifi-
cance of differences between means.
Table S1; for normally distributed paired data sets, paired sample t-tests were used to determine the significance of differences in
means between time points. For paired data sets not judged to be normally distributed, Wilcoxon Signed Ranks Tests were used to
determine the significance of differences in means between time points.
Differences in PB1 sizes between groups. Figure 5D data sets are non-paired and not judged to normally distributed, therefore
non-parametric ‘Mann-Whitney U Tests’ were used to determine the significance of differences in means.
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Figure S1. Related to Fig. 1. Representative raw data destruction profiles of D-box-B1-C (cerulean, 
pink) and Y170A-B1-V (blue) co-expressed in the same oocyte. (A) in an untreated oocyte, and (B) 
in oocytes on addition of cycloheximide as indicated (CHX). Note that the order of D-box-B1 and 
Y170A-B1 destruction did not depend on continued protein synthesis (which is prevented by 
cycloheximide), nor on their relative expression levels (i + ii comparison). PB1 extrusion time as 
indicated. 
Figure S2. Further destruction profiles of cyclin B1 truncations and mutations, an extension of Fig.  
3. (A) NTH sequence detail and nomenclature of venus tagged cyclin B1 mutants. (B) Mean 
destruction profiles of D-box-B1+NTH (n=22), D-box-B1+NTH DIY-A (n=18) and D-box-B1-V (n=34). 
(C) Mean destruction profiles of n190Y170A-B1 (n=36), n190LRQL-A (n=13), and n190DIY-A (n=21). 
Cyclin B1 mutants included in parts ‘C’ carry an additional I150T mutation. This residue falls within 
cyclin B1’s nuclear export signal, a sequence thought to be redundant in oocytes which do not have 
a nucleus. (D) Destruction profiles of Y170A-B1 and PMmut-B1 with (Y170A-B1* and PMmut-B1*) 
and without (Y170A-B1 and PMmut-B1) an I150T point mutation demonstrating that this amino acid 
switch did not affect either the timing, or the extent of destruction. Error bars ± SEM throughout.  
Figure S3. Related to Fig. 3C. Examples of individual cyclin B1 destruction traces. (A) Raw data 
demonstrating protein expression ranges are similar for PMmut-B1-V and Y170A-B1-V. Given that 
the cyclin B1 and fluorescent component of each construct are physically linked, we reasoned that 
by matching fluorescence levels, different cyclin B1 reporters are expressed at similar levels. Y170A-
B1-V expressing oocytes and PMmut-B1-V expressing oocytes are aligned to PB1 extrusion within 
treatment groups. Mean PB1 extrusion timings between treatment groups are identical. Thin traces 
represent individual oocytes while heavy traces indicate the mean. (B) Raw data above processed to 
normalize fluorescence values to 100%, 2.5 hours ahead of PB1 extrusion. This time point was 
selected as the initiation of cyclin B1 destruction in the average oocyte. Note that normalising data 
does not affect the observed order of destruction. Thin traces represent individual oocytes, while 
heavy traces indicate the mean. (C) Mean destruction profiles of Y170A-B1-V (n=18) and PMmut-B1-
V (n=18) after addition of cycloheximide (CHX) at the time indicated. Individual traces were aligned 
to GVBD and normalised to 100 a.u. at the point of CHX addition. Error bars ± SEM. (D) Oocytes 
5.5hrs post GVBD expressing Y170A-B1-V and PMmut-B1-V, incubated in the DNA dye SiR-DNA. 
Figure S4. Related to Fig. 4. Quantification of cyclin B1 and CDK1 in mouse oocytes 5.5 h post 
GVBD using a 1:1 cyclin B1:CDK1 protein complex. (A) Western blot of known amounts of cyclin B1 
and CDK1 recombinant protein (purified complex) alongside known numbers of mitotic U2OS cells to 
quantify cyclin B1 and CDK1 protein bands in U2OS cells (cell numbers indicated above). (B) Band 
densities of ‘purified complex’ lanes in part ‘A’ plotted relative to protein amount in ng. (C) 
Calculated amounts of cyclin B1 and CDK1 in 1000 U2OS cells from ‘A’ using the equation from ‘B’. 
(D) Western blot of mitotic mouse embryonic fibroblasts (MEFs), U2OS cells, oocytes collected 5.5 
hours post GVBD and 1.5 ng of cyclin B1 + 1.5 ng of CDK1 recombinant protein (cell numbers 
indicated above). Note the difference in the balance of cyclin B1 and CDK1 in the mitotic cell cycles 
of MEF’s where CDK1 is in excess. (E) Using the same strategy as in ‘B’ and ‘C’, cyclin B1 and CDK1 
band densities from part ‘D’ were used to relate cyclin B1 and CDK1 protein levels in oocytes to an 
equivalent number of U2OS cells. From this cyclin B1 and CDK1 protein amounts were calculated per 
oocyte. We calculate the ratio of cyclin B1:CDK1 to be approximately 6:1. All mitotic cell lysates are 
prepared from cells arrested in nocodazole and collected by shake off.  
(F) Western blots of control and cyclin B1 morpholino (MO) injected oocytes collected 5.5 hours post 
GVBD (numbers of oocytes loaded per lane are indicated). The upper blot was probed for cyclin B1, 
and the lower for CDK1 (2 different exposures). Quantification of protein bands indicates a 67% 
knockdown of cyclin B1 in cyclin B1 morpholino injected oocytes. The loss of cyclin B1 also results in 
a 12% loss of CDK1 protein. The ratio of cyclin B1:CDK1 was therefore calculated to be ~2.25:1 in 
cyclin B1 MO oocytes 5.5 hours post GVBD. Note that CDK1 levels are unchanged between GV stage 
and 5.5 hours post GVBD. (G) Western blot of 40 oocytes injected with Y170A-B1-V, probed for cyclin 
B1. Oocytes were collected and lysed 5 hours post GVBD. In order to be sure of detecting exogenous 
cyclin B1, 4-fold greater needle concentrations of cRNA were used for microinjection of blotting 
oocytes than those used to report cyclin B1 destruction profiles. We determined that all cyclin B1 
reporters are expressed at between 8-13% of endogenous at their peak prior to destruction. All 
western blot images presented are scanned X-ray film. 
Figure S5. Related to Fig. 4B. Validation of the CDK1 activity FRET sensor in oocytes. FRET ratios 
from oocytes expressing a CDK1 activity biosensor are able to detect changes in the balance 
between cyclin B1:CDK1 kinase activity and antagonistic phosphatase(s) activity. (A) Mean FRET 
ratios in oocytes after: green trace, no further treatment (n=72); blue trace, addition of the CDK1 
inhibitor flavopiridol, demonstrating a rapid reduction in FRET signal (n=12); yellow trace, following 
overexpression of non-destructible cyclin B1 (Δ90 cyclin B1 lacks a D-box, n=23); red trace, inactive 
control biosensor in which the phosphorylated Ser126 is mutated to Ala (n=12). Inhibitors were 
added to the medium and PBs were extruded at the times indicated. 
The Δ90 cyclin B1 experiment demonstrates that the pre-anaphase loss of FRET signal in control 
oocytes is the result of CDK1-bound cyclin B1 destruction. Oocytes overexpressing Δ90 cyclin B1 
show no loss of FRET, indicating a stable balance between CDK1 kinase activity and phosphatase 
activity. In control oocytes, the loss of CDK1 activity switches the balance in favour phosphatase 
activity and the FRET ratio drops. This experiment also demonstrates that CDK1 levels, not cyclin B1 
levels, are rate limiting since CDK1 activity in oocytes overexpressing Δ90 cyclin B1 does not increase 
beyond that of control cells.  
(B) Mean FRET ratios from a pool of oocytes expressing the CDK1 biosensor following either no 
further treatment (green trace n=18) or microinjection of 2pg of unlabelled recombinant CDK1 
protein, (black trace n=17/29). Oocytes injected with CDK1 are delayed in PB1 extrusion as 
indicated, presumably due to the need to disassemble greater numbers of cyclin B1:CDK1 
complexes. 12/29 CDK1 protein injected oocytes failed to extrude a polar body and are not included. 
Given that the loss of CDK1 activity must be abrupt to generate an irreversible anaphase switch (Holt 
et al., 2008), we reasoned that the time lag in destroying more CDK1 associated cyclin B1 perturbed 
this switch resulting in a stalled anaphase. This experiment serves to demonstrate that we are 
working within the dynamic range of the FRET sensor and provides further evidence that CDK1 is 
rate limiting. Means ± SEM are shown.  
Figure S6. Related to Fig 5. D-box substrates are targeted earlier where the amount of excess cyclin 
B1 is restricted. (A) Example replicate showing mean, raw data, CDK1 activity FRET ratios in 
untreated (n=18) and cyclin B1 MO injected oocytes (n=26) demonstrating that absolute CDK1 
activity does not differ until approximately 2-2.5 hours ahead of polar body extrusion. Time 0 = PB1 
extrusion in control oocytes. 
Destruction of D-box-B1-V in untreated (n=20) and cyclin B1 MO treated oocytes (n=31) as; (B) raw 
data traces aligned at GVBD, thin traces represent individual oocytes, while heavy traces represent 
the average; (C) GVBD aligned data normalised to 100% at the maximum fluorescence prior to PB1 
extrusion. (D) Mean destruction profiles of securin-V in control oocytes (n=15 oocytes) and cyclin B1 
MO oocytes (n=15 oocytes). Error bars ± SEM. 
Figure S7. Related to Fig. 6. Spindle parameter measurements in control and cyclin B1 MO oocytes. 
Box plots of relative spindle length and width in control oocytes (green) and cyclin B1 MO oocytes 
(purple) at (A) 5.5hrs post GVBD and (B) ‘pre-anaphase’ (the last image collected before anaphase). 
(C) Box plots showing relative chromosome dispersion in control (green) and cyclin B1 MO oocytes 
(purple) at 5.5hrs post GVBD and ‘pre-anaphase’. (D) Box plots showing the relative distance of the 
spindle from the cortex in control (green) and cyclin B1 MO oocytes (purple) at 5.5hrs post GVBD 
and ‘pre-anaphase’. * denotes a significant difference in means P<0.05. ** denotes a significant 
difference in means P<0.005. (E) Given that cyclin B1 MO treated oocytes extrude PBs earlier than 
control oocytes (~40 minutes earlier), a pre-anaphase measurement (taken a maximum of 15 
minutes ahead of anaphase) in cyclin B1 MO oocytes could be argued to be more closely analogous 
to images of control oocytes taken 30-45 minutes earlier (45-60 minutes’ pre-anaphase). Therefore, 
we quantified changes in chromosome dispersion at earlier time points in control oocytes. We 
suggest that chromosomes do not simply condense on the metaphase plate within the final 30-45 
minutes. Instead, as previously reported (Kitajima et al., 2011), this is a gradual process. We suggest 
that in cyclin B1 MO oocytes the lack of chromosome congression at anaphase is not simply due to 
premature cytokinesis.  
 
Table S1. Related to Figs. 5 and 6.  P-values summarising the significance of differences in 
measurements of spindle morphology between time points. Between 5.5 hours post GVBD and 
pre- anaphase, differences in spindle length and width were not judged to change in either control 
or cyclin B1 MO oocytes. Between the same time points, chromosomes congressed in control 
oocytes (P=0.003, green). However, a much more modest reduction in the dispersion of 
chromosomes was not judged to be significant in cyclin B1 MO oocytes (P=0.097, pink). In both 
control and cyclin B1 MO oocytes the spindle moved significantly closer to the cortex of the oocyte. 
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